ClinConnect ClinConnect Logo
Search / Trial NCT05597904

Background of Different Phenotypes of Coeliac Disease

Launched by TAMPERE UNIVERSITY HOSPITAL · Oct 25, 2022

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Coeliac Disease Dermatitis Herpetiformis Gluten Free Diet Transglutaminase Microbiata

ClinConnect Summary

This clinical trial is studying different forms of coeliac disease and dermatitis herpetiformis, which are conditions that affect how the body reacts to gluten, a protein found in wheat, barley, and rye. Researchers want to learn about the genetic and immune differences between these conditions and find specific markers that can help predict how each person will respond to treatment. This information could lead to better management of these diseases in the future.

The study is currently looking for participants aged 18 and older. If you have been diagnosed with coeliac disease or dermatitis herpetiformis, or if you are a friend or family member of someone with these conditions, you may be eligible to participate. However, if you are under 18 or haven’t had your diagnosis confirmed, you wouldn't be able to join. Participants will undergo tests and provide samples to help researchers gather the necessary information. Your involvement could contribute to important discoveries in understanding and treating these conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Cohorts 1 and 2: coeliac disease or dermatitis herpetiformis diagnosis
  • Cohort 3: friend or non-related family member of coeliac disease or dermatitis herpetiformis patient
  • Exclusion Criteria:
  • Cohorts 1-3: Age \<18 years
  • Cohorts 1 and 2: coeliac disease or dermatitis herpetiformis diagnosis not confirmed
  • Cohort 3: coeliac disease or dermatitis herpetiformis diagnosis

About Tampere University Hospital

Tampere University Hospital (TAYS) is a leading academic medical center in Finland, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, TAYS integrates cutting-edge medical practices with rigorous scientific investigation, focusing on improving patient outcomes and enhancing treatment modalities across various specialties. The hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to foster a multidisciplinary approach to medical research, ensuring that findings are translated into real-world applications for the benefit of patients and the broader healthcare community.

Locations

Tampere, , Finland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials